172 related articles for article (PubMed ID: 32875424)
1. A case of cytomegalovirus esophagitis during topical steroid therapy for eosinophilic esophagitis.
Suzaki K; Kobayashi K; Matsuoka M; Okura Y; Nozaka T; Yauchi M; Watabe T; Matsumoto T; Furumoto Y; Horiuchi T; Asano T; Fujiki K
Clin J Gastroenterol; 2020 Dec; 13(6):1046-1050. PubMed ID: 32875424
[TBL] [Abstract][Full Text] [Related]
2. High-resolution manometry in patients with eosinophilic esophagitis under topical steroid therapy-a prospective observational study (HIMEOS-study).
Nennstiel S; Bajbouj M; Becker V; Slotta-Huspenina J; Wagenpfeil S; Schmid RM; Schlag C
Neurogastroenterol Motil; 2016 Apr; 28(4):599-607. PubMed ID: 26891170
[TBL] [Abstract][Full Text] [Related]
3. Recent insights on the use of topical steroids in eosinophilic esophagitis.
Reddy A; Ashat D; Murali AR
Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):953-963. PubMed ID: 32567417
[TBL] [Abstract][Full Text] [Related]
4. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Murali AR; Gupta A; Attar BM; Ravi V; Koduru P
J Gastroenterol Hepatol; 2016 Jun; 31(6):1111-9. PubMed ID: 26699695
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilic esophagitis--treatment of eosinophilic esophagitis with drugs: corticosteroids.
von Arnim U; Malfertheiner P
Dig Dis; 2014; 32(1-2):126-9. PubMed ID: 24603395
[TBL] [Abstract][Full Text] [Related]
6. Histologic response to steroids in eosinophilic esophagitis is dependent on delivery compound.
Schupack DA; Johnson K; Akambase JA; Geno D; Lavey C; Lennon RJ; Ravi K; Snyder DL; Katzka DA; Alexander JA
Dis Esophagus; 2022 Dec; 36(1):. PubMed ID: 35780320
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-associated esophagitis on early esophageal cancer in immunocompetent host: a case report.
Murakami D; Harada H; Yamato M; Amano Y
Gut Pathog; 2021 Apr; 13(1):24. PubMed ID: 33863376
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
Parente F; Bianchi Porro G
Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilic esophagitis (EoE); a disease that must not be neglected - implications of esophageal rupture and its management.
Larsson H; Attwood S
BMC Gastroenterol; 2020 Jun; 20(1):185. PubMed ID: 32527222
[TBL] [Abstract][Full Text] [Related]
12. Emerging therapies for eosinophilic esophagitis.
Greuter T; Hirano I; Dellon ES
J Allergy Clin Immunol; 2020 Jan; 145(1):38-45. PubMed ID: 31705907
[TBL] [Abstract][Full Text] [Related]
13. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
Munoz-Persy M; Lucendo AJ
Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
[TBL] [Abstract][Full Text] [Related]
14. Impact of Dose Reduction of Topical Steroids to Manage Adrenal Insufficiency in Pediatric Eosinophilic Esophagitis.
Nistel M; Furuta GT; Pan Z; Hsu S
J Pediatr Gastroenterol Nutr; 2023 Jun; 76(6):786-792. PubMed ID: 36306502
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic esophagitis in patients with esophageal atresia and chronic dysphagia.
Kassabian S; Baez-Socorro V; Sferra T; Garcia R
World J Gastroenterol; 2014 Dec; 20(47):18038-43. PubMed ID: 25548504
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.
Min SB; Nylund CM; Baker TP; Ally M; Reinhardt B; Chen YJ; Nazareno L; Moawad FJ
J Clin Gastroenterol; 2017 Feb; 51(2):127-135. PubMed ID: 27479142
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis.
Arasi S; Costa S; Magazzù G; Ieni A; Crisafulli G; Caminiti L; Chiera F; Vaccaro M; Del Giudice MM; Pajno GB
Ital J Pediatr; 2016 Mar; 42():32. PubMed ID: 27000314
[TBL] [Abstract][Full Text] [Related]
18. SERPINB12 as a possible marker of steroid dependency in children with eosinophilic esophagitis: A pilot study.
Oliva S; Laudadio I; Fulci V; Rossetti D; Isoldi S; Stronati L; Carissimi C
Dig Liver Dis; 2020 Feb; 52(2):158-163. PubMed ID: 31653522
[TBL] [Abstract][Full Text] [Related]
19. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids.
Nennstiel S; Schlag C
World J Gastroenterol; 2020 Sep; 26(36):5395-5407. PubMed ID: 33024392
[TBL] [Abstract][Full Text] [Related]
20. Severe esophagitis associated with cytomegalovirus during concurrent chemoradiotherapy for esophageal cancer.
Aizawa R; Matsumoto S; Uneno Y; Nishikawa Y; Ozaki Y; Mori Y; Kanai M; Ishida Y; Sakanaka K; Hiraoka M; Muto M
Jpn J Clin Oncol; 2017 Sep; 47(9):885-888. PubMed ID: 28591845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
